Ownership history in Executive Wealth Management, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which Executive Wealth Management, LLC reported a position in ROYALTY PHARMA PLC (RPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | REDUCED | 74,700 | -22,839 | -23.4% | 0.27% | $2.1M | $27.23 |
| 2024 Q2 | ADDED | 97,539 | +4,583 | +4.9% | 0.47% | $2.6M | $25.18 |
| 2024 Q1 | ADDED | 92,956 | +37,043 | +66.3% | 0.24% | $2.8M | $28.79 |
| 2023 Q4 | ADDED | 55,913 | +4,886 | +9.6% | 0.15% | $1.6M | $26.44 |
| 2023 Q3 | ADDED | 51,027 | +8,755 | +20.7% | 0.14% | $1.4M | $25.35 |
| 2023 Q2 | ADDED | 42,272 | +21,682 | +105.3% | 0.13% | $1.3M | $28.52 |
| 2023 Q1 | INITIATED | 20,590 | — | — | 0.08% | $742K | $33.23 |
As of 2025 Q4 — sorted by position size